Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy.
Chiricozzi A, Di Nardo L, Talamonti M, Galluzzo M, De Simone C, Fabbrocini G, Marzano AV, Girolomoni G, Offidani A, Rossi MT, Bianchi L, Cristaudo A, Fierro MT, Stingeni L, Pellacani G, Argenziano G, Patrizi A, Pigatto P, Romanelli M, Savoia P, Rubegni P, Foti C, Milanesi N, Belloni Fortina A, Bongiorno MR, Grieco T, Di Nuzzo S, Fargnoli MC, Carugno A, Motolese A, Rongioletti F, Amerio P, Balestri R, Potenza C, Micali G, Patruno C, Zalaudek I, Lombardo M, Feliciani C, Antonelli F, Ferrucci SM, Guarneri F, Peris K. Chiricozzi A, et al. Among authors: antonelli f. Dermatitis. 2022 May-Jun 01;33(3):e25-e29. doi: 10.1097/DER.0000000000000814. Epub 2021 Dec 10. Dermatitis. 2022. PMID: 35129461 Free PMC article. No abstract available.
Similar Levels of Efficacy of Two Different Maintenance Doses of Adalimumab on Clinical Severity and Quality of Life of Patients with Hidradenitis Suppurativa.
Fania L, Giovanardi G, Samela T, Caposiena D, Chiricozzi A, Antonelli F, Saraceni P, Elia F, Garcovich S, Ciccone D, Cannizzaro MV, Miraglia E, Iacovino C, Giustini S, Skroza N, Mambrin A, Potenza C, Bianchi L, Peris K, Abeni D. Fania L, et al. Among authors: antonelli f. J Clin Med. 2022 Jul 12;11(14):4037. doi: 10.3390/jcm11144037. J Clin Med. 2022. PMID: 35887799 Free PMC article.
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study.
Chiricozzi A, Balato A, Fabbrocini G, Di Nardo L, Babino G, Rossi M, Esposito M, Bertoldi AM, Girolomoni G, Gambardella A, Antonelli F, Patruno C, Fargnoli MC, Argenziano G, Peris K. Chiricozzi A, et al. Among authors: antonelli f. J Am Acad Dermatol. 2023 Dec;89(6):1251-1253. doi: 10.1016/j.jaad.2023.05.001. Epub 2023 May 9. J Am Acad Dermatol. 2023. PMID: 37169293 No abstract available.
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation.
Chiricozzi A, Ortoncelli M, Schena D, Gori N, Ferrucci SM, Babino G, Napolitano M, Fargnoli MC, Stingeni L, Rossi M, Romanelli M, Balestri R, Pellegrino M, Parodi A, Bertoldi AM, Palazzo G, Antonelli F, Pitino A, Tripepi G, Fabbrocini G, Balato A, Marzano AV, Girolomoni G, Ribero S, Peris K. Chiricozzi A, et al. Among authors: antonelli f. Am J Clin Dermatol. 2023 Nov;24(6):953-961. doi: 10.1007/s40257-023-00798-0. Epub 2023 Jun 15. Am J Clin Dermatol. 2023. PMID: 37322324 Free PMC article.
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation.
Chiricozzi A, Ortoncelli M, Schena D, Gori N, Ferrucci SM, Babino G, Napolitano M, Fargnoli MC, Stingeni L, Rossi M, Romanelli M, Balestri R, Pellegrino M, Parodi A, Bertoldi AM, Palazzo G, Antonelli F, Pitino A, Tripepi G, Fabbrocini G, Balato A, Marzano AV, Girolomoni G, Ribero S, Peris K. Chiricozzi A, et al. Among authors: antonelli f. Am J Clin Dermatol. 2023 Nov;24(6):963-964. doi: 10.1007/s40257-023-00813-4. Epub 2023 Aug 19. Am J Clin Dermatol. 2023. PMID: 37597128 Free PMC article. No abstract available.
163 results